Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.

  title={Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.},
  author={Julie Bruneau and Geng Zang and Michał Abrahamowicz and Didier Jutras-Aswad and Mark Daniel and {\'E}lise Roy},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  volume={58 6},
  • J. Bruneau, G. Zang, É. Roy
  • Published 15 March 2014
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
BACKGROUND Notification of hepatitis C virus (HCV) positive status is known to have short-term impacts on subsequent alcohol, drug use and injection behaviors among persons who inject drugs (PWID). It remains to be established whether postscreening behavioral changes extend over time for PWID and whether screening test notification has behavioral impacts among HCV-negative PWID. This study sought to longitudinally assess substance use and injection behaviors after HCV status notification among… 

Figures and Tables from this paper

Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis
Finding of present study was that unprotected sex had a negative association with HCV testing, and prevention programs that address age, sex, and level of education are strongly recommended to prioritize HCV risk reduction strategies.
Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement
While a host of predisposing factors seems to hamper timely contacts with PCP among high‐risk PWID, community‐based support services may play an important role in initiating dialogue with primary healthcare services in this population.
Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort Study
Although HCV testing and positive status rates are high among PWID in Ottawa, Canada, few have received HCV treatment, and innovative initiatives to increase access toHCV treatment for PWID are urgently needed.
High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011–2014: missed opportunities for hepatitis C testing
To increase early diagnosis and facilitate treatment, HCV-testing should be offered in all facilities, where NI can be reached, especially low-threshold drug services and addiction therapy, but also prisons, hospitals and practices without OST.
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
A relatively high awareness of HIV and HCV infection status among PWID is found, Nevertheless, access to appropriate testing, counselling and care services targeted to the needs of PWID should be further improved, particularly concerning HCV.


The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.
A very large proportion of injection drug users who had hepatitis C were unaware of it, and they were engaging in more risk behaviors than those who were aware of their positive status.
The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
Prescription opioid injectors who do not inject heroin are at greater risk for HCV seroconversion than are those injecting both heroin and prescription opioids.
HCV status knowledge and risk behaviours amongst intravenous drug users
This study suggests that particular sexual and injecting risk-behaviours are associated with not knowing HCV status, as HCV-unknown IDUs are likely to be at the risk of transmitting HCV or acquiring other infections.
Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young Injectors
Expanded availability of HCV screening with high quality counseling is clearly needed for this population to promote the health of chronically HCV-infected IDUs and to decrease risk among injectors susceptible to acquiring or transmitting HCV.
Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden
Knowing of HCV status and assessment of health consequences with HCV infection were not enough to change injecting risk behaviours, and sharing of other injecting equipment was a more important risk factor than sharing needles for participants with verified HCV-positive status.
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
These evidence-based recommendations to increase the proportion of hepatitis C virus-infected persons who know their status and are linked to appropriate care and treatment and address brief alcohol screening, as alcohol accelerates progression of liver disease among HCV- Infected individuals.
Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
Although annual screening for antibodies to HIV and HCV is modestly cost effective compared to no screening, more frequent screening for HIV provides additional benefit at less cost.
Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population.
This study examined test-retest reliabilities of self-reported human immunodeficiency virus (HIV) sexual and drug injection behaviors among 246 prior drug users admitted to either of two residential